Depression in multiple sclerosis

References

• Alonso, J., Angermeyer, M.C., Bernert, S., Bruffaerts, R., Brugha, T.S., Bryson, H., … Vollebergh, W.A. (2004). Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, Supplementum, 420, 21–27. doi:10.1111/j.1600-0047.2004.00327.x
   PubMedGoogle Scholar
• American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5). (5 ed.). Washington (DC): American Psychiatric Publishing.
   Google Scholar
• Amtmann, D., Kim, J., Chung, H., Bamer, A.M., Askew, R.L., Wu, S., … Johnson, K.L. (2014). Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabilitation Psychology, 59, 220–229. doi:10.1037/a0035919
   PubMed Web of Science ®Google Scholar
• Andresen, E.M., Malmgren, J.A., Carter, W.B., & Patrick, D.L. (1994). Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American Journal of Preventive Medicine, 10, 77–84.
   PubMed Web of Science ®Google Scholar
• Angst, J., Sellaro, R., Stassen, H.H., & Gamma, A. (2005). Diagnostic conversion from depression to bipolar disorders: Results of a long-term prospective study of hospital admissions. Journal of Affective Disorders, 84, 149–157. doi:10.1016/S0165-0327(03)00195-2
   PubMed Web of Science ®Google Scholar
• Bamer, A.M., Cetin, K., Johnson, K.L., Gibbons, L.E., & Ehde, D.M. (2008). Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis. General Hospital Psychiatry, 30, 311–317. doi:10.1016/j.genhosppsych.2008.04.006
   PubMed Web of Science ®Google Scholar
• Barak, Y., Ur, E., & Achiron, A. (1999). Moclobemide treatment in multiple sclerosis patients with comorbid depression: An open-label safety trial. The Journal of Neuropsychiatry and Clinical Neurosciences, 11, 271–273. doi:10.1176/jnp.11.2.271
   PubMed Web of Science ®Google Scholar
• Bayas, A., Schuh, K., Baier, M., Vormfelde, S.V., & Group, R.S. (2016). Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: A multicentre, open-label study - REGAIN. Therapeutic Advances in Neurological Disorders, 9, 378–388. doi:10.1177/1756285616651197
   PubMed Web of Science ®Google Scholar
• Beal, C.C., Stuifbergen, A.K., & Brown, A. (2007). Depression in multiple sclerosis: A longitudinal analysis. Archives of Psychiatric Nursing, 21, 181–191. doi:10.1016/j.apnu.2007.02.008
   PubMed Web of Science ®Google Scholar
• Bebbington, P. (1992). Welcome to ICD-10, and welcome to SCAN. Social Psychiatry and Psychiatric Epidemiology, 27, 255–257. doi:10.1007/BF00788894
   PubMed Web of Science ®Google Scholar
• Benedict, R.H., Fishman, I., McClellan, M.M., Bakshi, R., & Weinstock-Guttman, B. (2003). Validity of the beck depression inventory-fast screen in multiple sclerosis. Multiple Sclerosis, 9, 393–396. doi:10.1191/1352458503ms902oa
   PubMed Web of Science ®Google Scholar
• Berrigan, L.I., Fisk, J.D., Patten, S.B., Tremlett, H., Wolfson, C., … Warren, S. (2016). Impact of Comorbidity on Multiple Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity. Neurology, 86, 1417–1424. doi:10.1212/WNL.0000000000002564
   PubMed Web of Science ®Google Scholar
• Bombardier, C.H., Blake, K.D., Ehde, D.M., Gibbons, L.E., Moore, D., & Kraft, G.H. (2004). Alcohol and drug abuse among persons with multiple sclerosis. Multiple Sclerosis, 10, 35–40. doi:10.1191/1352458504ms989oa
   PubMed Web of Science ®Google Scholar
• Brenner, P., Burkill, S., Jokinen, J., Hillert, J., Bahmanyar, S., & Montgomery, S. (2016). Multiple sclerosis and risk of attempted and completed suicide - A cohort study. European Journal of Neurology, 23, 1329–1336. doi:10.1111/ene.13029
   PubMed Web of Science ®Google Scholar
• Brønnum-Hansen, H., Stenager, E., Stenager, E.N., & Koch-Henriksen, N. (2005). Suicide among Danes with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 76, 1457–1459. doi:10.1136/jnnp.2004.056747
   PubMed Web of Science ®Google Scholar
• Carta, M.G., Balestrieri, M., Murru, A., & Hardoy, M.C. (2009). Adjustment disorder: Epidemiology, diagnosis and treatment. Clinical Practice & Epidemiology in Mental Health, 5, 15. doi:10.1186/1745-0179-5-15
   PubMedGoogle Scholar
• Carta, M.G., Moro, M.F., Lorefice, L., Picardi, A., Trincas, G., Fenu, G., … Marrosu, M.G. (2014). Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life. Journal of Affective Disorders, 167, 192–197. doi:10.1016/j.jad.2014.05.024
   PubMed Web of Science ®Google Scholar
• Carta, M.G., Moro, M.F., Lorefice, L., Trincas, G., Cocco, E., Del Giudice, E., … Marrosu, M.G. (2014). The risk of bipolar disorders in multiple sclerosis. Journal of Affective Disorders, 155, 255–260. doi:10.1016/j.jad.2013.11.008
   PubMed Web of Science ®Google Scholar
• Chwastiak, L., Ehde, D.M., Gibbons, L.E., Sullivan, M., Bowen, J.D., & Kraft, G.H. (2002). Depressive symptoms and severity of illness in multiple sclerosis: Epidemiological study of a large community sample. The American Journal of Psychiatry, 159, 1862–1868. doi:10.1176/appi.ajp.159.11.1862
   PubMed Web of Science ®Google Scholar
• Colasanti, A., Guo, Q., Giannetti, P., Wall, M.B., Newbould, R.D., Bishop, C., … Rabiner, E.A. (2016). Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis. Biological Psychiatry, 80, 62–72. doi:10.1016/j.biopsych.2015.11.022
   PubMed Web of Science ®Google Scholar
• Crawford, P., & Webster, N.J. (2009). Validity of including somatic items on the Beck Depression Inventory-II. International Journal of MS Care, 11, 167–173. doi:10.7224/1537-2073-11.4.167
   Google Scholar
• Dalgas, U., Stenager, E., Sloth, M., & Stenager, E. (2015). The effect of exercise on depressive symptoms in multiple sclerosis based on a meta-analysis and critical review of the literature. European Journal of Neurology, 22, 443–e434. doi:10.1111/ene.12576
   PubMed Web of Science ®Google Scholar
• Ehde, D.M., Kraft, G.H., Chwastiak, L., Sullivan, M.D., Gibbons, L.E., Bombardier, C.H., & Wadwani, R. (2008). Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. General Hospital Psychiatry, 30, 40–48. doi:10.1016/j.genhosppsych.2007.08.002
   PubMed Web of Science ®Google Scholar
• Endicott, J., & Spitzer, R.L. (1978). A diagnostic interview: The schedule for affective disorders and schizophrenia. Archives of General Psychiatry, 35, 837–844. doi:10.1001/archpsyc.1978.01770310043002
   PubMed Web of Science ®Google Scholar
• Ensari, I., Motl, R.W., & Pilutti, L.A. (2014). Exercise training improves depressive symptoms in people with multiple sclerosis: Results of a meta-analysis. Journal of Psychosomatic Research, 76, 465–471. doi:10.1016/j.jpsychores.2014.03.014
   PubMed Web of Science ®Google Scholar
• Feinstein, A., & Feinstein, K. (2001). Depression associated with multiple sclerosis - Looking beyond diagnosis to symptom expression. Journal of Affective Disorders, 66, 193–198. doi:10.1016/S0165-0327(00)00298-6
   PubMed Web of Science ®Google Scholar
• Feinstein, A., Magalhaes, S., Richard, J.F., Audet, B., & Moore, C. (2014). The link between multiple sclerosis and depression. Nature Reviews Neurology, 10, 507–517. doi:10.1038/nrneurol.2014.139
   PubMed Web of Science ®Google Scholar
• Feinstein, A., O'Connor, P., Akbar, N., Moradzadeh, L., Scott, C.J., & Lobaugh, N.J. (2010). Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients. Multiple Sclerosis, 16, 189–196. doi:10.1177/1352458509355461
   PubMed Web of Science ®Google Scholar
• Feinstein, A., O'Connor, P., & Feinstein, K. (2002). Multiple sclerosis, interferon beta-1b and depression A prospective investigation. Journal of Neurology, 249, 815–820. doi:10.1007/s00415-002-0725-0
   PubMed Web of Science ®Google Scholar
• Fiest, K.M., Walker, J.R., Bernstein, C.N., Graff, L.A., Zarychanski, R., … Abou-Setta, A.M. (2016). Managing the effects of psychiatric comorbidity in chronic immunoinflammatory systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Multiple Sclerosis and Related Disorders, 5, 12–26. doi:10.1016/j.msard.2015.10.004
   PubMed Web of Science ®Google Scholar
• First, M., Spitzer, R., Gibbon, M., & Williams, J. (1997). Structured clinical interview for DSM-IV Axis I disorders. Research version, non-patient edition (SCID-I/NP). New York: New York State Psychiatric Institute.
   Google Scholar
• Fischer, A., Schroder, J., Vettorazzi, E., Wolf, O.T., Pottgen, J., Lau, S., … Gold, S.M. (2015). An online programme to reduce depression in patients with multiple sclerosis: A randomised controlled trial. The Lancet Psychiatry, 2, 217–223. doi:10.1016/S2215-0366(14)00049-2
   PubMed Web of Science ®Google Scholar
• Fragoso, Y.D., Gomes, S., Goncalves, M.V., Machado, S.C., Morales Rde, R., Oliveira, F.T., … Stoney, P.N. (2015). Patients with multiple sclerosis do not necessarily consume more alcohol or tobacco than the general population. Arquivos de Neuro-Psiquiatria, 73, 828–833. doi:10.1590/0004-282X20150117
   PubMed Web of Science ®Google Scholar
• Goldenberg, M.M. (2012). Multiple sclerosis review. p T, 37, 175–184.
   PubMedGoogle Scholar
• Goldman Consensus Group. (2005). The goldman consensus statement on mood disorders in multiple sclerosis. Multiple Sclerosis, 11, 328–337.
   PubMed Web of Science ®Google Scholar
• Hind, D., Cotter, J., Thake, A., Bradburn, M., Cooper, C., Isaac, C., & House, A. (2014). Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: A systematic review and meta-analysis. BMC Psychiatry, 14, 5. doi:10.1186/1471-244X-14-5
   PubMed Web of Science ®Google Scholar
• Hind, D., Kaklamanou, D., Beever, D., Webster, R., Lee, E., Barkham, M., & Cooper, C. (2016). The assessment of depression in people with multiple sclerosis: A systematic review of psychometric validation studies. BMC Psychiatry, 16, 278 doi:10.1186/s12888-016-0931-5
   PubMed Web of Science ®Google Scholar
• Hind, D., O'Cathain, A., Cooper, C.L., Parry, G.D., Isaac, C.L., Rose, A., … Sharrack, B. (2010). The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: A qualitative study of people with multiple sclerosis. Psychology & Health, 25, 699–712. doi:10.1080/08870440902842739
   PubMed Web of Science ®Google Scholar
• Hunter, S.F., Agius, M., Miller, D.M., Cutter, G., Barbato, L., McCague, K., … Hollander, E. (2016). Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial. Journal of the Neurological Sciences, 365, 190–198. doi:10.1016/j.jns.2016.03.024
   PubMed Web of Science ®Google Scholar
• IFNB Multiple Sclerosis Study Group. (1995). Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology, 45, 1277–1285.
   PubMed Web of Science ®Google Scholar
• Joffe, R.T., Lippert, G.P., Gray, T.A., Sawa, G., & Horvath, Z. (1987a). Mood disorder and multiple sclerosis. Archives of Neurolog, 44, 376–378. doi:10.1001/archneur.1987.00520160018007
   PubMed Web of Science ®Google Scholar
• Joffe, R.T., Lippert, G.P., Gray, T.A., Sawa, G., & Horvath, Z. (1987b). Personal and family history of affective illness in patients with multiple sclerosis. Journal of Affective Disorders, 12, 63–65.
   PubMed Web of Science ®Google Scholar
• Johansson, V., Lundholm, C., Hillert, J., Masterman, T., Lichtenstein, P., Landen, M., & Hultman, C.M. (2014). Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort. Multiple Sclerosis, 20, 1881–1891. doi:10.1177/1352458514540970
   PubMed Web of Science ®Google Scholar
• Kessler, R.C., Andrews, G., Mroczek, D., Ustun, B., & Wittchen, H.U. (1998). The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). International Journal of Methods in Psychiatric Research, 7, 171–185.
   Google Scholar
• Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., … Wang, P.S. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289, 3095–3105.
   PubMed Web of Science ®Google Scholar
• Kessler, R.C., & Ustun, T.B. (2004). The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 13, 83–121.
   Web of Science ®Google Scholar
• Klapper, J.A. (1994). Interferon beta treatment of multiple sclerosis. Neurology, 44, 188.
   PubMed Web of Science ®Google Scholar
• Koch, M.W., Glazenborg, A., Uyttenboogaart, M., Mostert, J., & De Keyser, J. (2011). Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database of Systematic Reviews, CD007295. doi:10.1002/14651858.CD007295.pub2
   Web of Science ®Google Scholar
• Koch, M.W., Patten, S., Berzins, S., Zhornitsky, S., Greenfield, J., Wall, W., & Metz, L.M. (2015). Depression in multiple sclerosis: A long-term longitudinal study. Multiple Sclerosis, 21, 76–82. doi:10.1177/1352458514536086
   PubMed Web of Science ®Google Scholar
• Kroenke, K., & Spitzer, R.L. (2002). The PHQ-9: A new depression diagnostic and severity measure. Psychiatric Annals, 32, 7–1.
   Web of Science ®Google Scholar
• Lorefice, L., Fenu, G., Trincas, G., Moro, M.F., Frau, J., Coghe, G.C., … Carta, M.G. (2015). Progressive multiple sclerosis and mood disorders. Neurological Sciences, 36, 1625–1631. doi:10.1007/s10072-015-2220-3
   PubMed Web of Science ®Google Scholar
• Manning, K.J. (2016). Hippocampal neuroinflammation and depression: Relevance to multiple sclerosis and other neuropsychiatric illnesses. Biological Psychiatry, 80, e1–e2. doi:10.1016/j.biopsych.2016.05.001
   PubMed Web of Science ®Google Scholar
• Marrie, R.A., Fisk, J.D., Tremlett, H., Wolfson, C., Warren, S., & Tennakoon, A. & Impact of Comorbidity on Multiple Sclerosis (2015). Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology, 85, 1972–1979. doi:10.1212/WNL.0000000000002174
   PubMed Web of Science ®Google Scholar
• Marrie, R.A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P.S., … Reider, N. (2015). The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review. Multiple Sclerosis, 21, 305–317. doi:10.1177/1352458514564487
   PubMed Web of Science ®Google Scholar
• McKay, K.A., Tremlett, H., Fisk, J.D., Patten, S.B., Fiest, K., … Berrigan, L. & Impact of Comorbidity on Multiple Sclerosis (2016). 22, 685–693. Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study. Multiple Sclerosis, 22, 685–693. doi:10.1177/1352458515599073
   PubMed Web of Science ®Google Scholar
• Miller, A.H., & Raison, C.L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16, 22–34. doi:10.1038/nri.2015.5
   PubMed Web of Science ®Google Scholar
• Minden, S.L., Feinstein, A., Kalb, R.C., Miller, D., Mohr, D.C., Patten, S.B., … Narayanaswami, P. (2014). Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82, 174–181. doi:10.1212/WNL.0000000000000013
   PubMed Web of Science ®Google Scholar
• Minden, S.L., Orav, J., & Reich, P. (1987). Depression in multiple sclerosis. General Hospital Psychiatry, 9, 426–434.
   PubMed Web of Science ®Google Scholar
• Minden, S.L., Orav, J., & Schildkraut, J.J. (1988). Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology, 38, 1631–1634.
   PubMed Web of Science ®Google Scholar
• Minden, S.L., & Schiffer, R.B. (1990). Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Archives of Neurology, 47, 98–104.
   PubMed Web of Science ®Google Scholar
• Mohr, D.C., Boudewyn, A.C., Goodkin, D.E., Bostrom, A., & Epstein, L. (2001). Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology, 69, 942–949.
   PubMed Web of Science ®Google Scholar
• Mohr, D.C., Goodkin, D.E., Likosky, W., Gatto, N., Baumann, K.A., & Rudick, R.A. (1997). Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Archives of Neurology, 54, 531–533.
   PubMed Web of Science ®Google Scholar
• Mohr, D.C., Likosky, W., Bertagnolli, A., Goodkin, D.E., Van Der Wende, J., Dwyer, P., & Dick, L.P. (2000). Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. Journal of Consulting and Clinical Psychology, 68, 356–361.
   PubMed Web of Science ®Google Scholar
• Montalban, X., Comi, G., O'Connor, P., Gold, S., de Vera, A., Eckert, B., & Kappos, L. (2011). Oral fingolimod (FTY720) in relapsing multiple sclerosis: Impact on health-related quality of life in a phase II study. Multiple Sclerosis, 17, 1341–1350. doi:10.1177/1352458511411061
   PubMed Web of Science ®Google Scholar
• Morrow, S.A., Barr, J., Rosehart, H., & Ulch, S. (2015). Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses. Journal of Affective Disorders, 187, 142–146. doi:10.1016/j.jad.2015.08.040
   PubMed Web of Science ®Google Scholar
• Mura, G., Moro, M.F., Patten, S.B., & Carta, M.G. (2014). Exercise as an add-on strategy for the treatment of major depressive disorder: A systematic review. CNS Spectrums, 19, 496–508. doi:10.1017/S1092852913000953
   PubMed Web of Science ®Google Scholar
• Murray, T.J. (2006). Diagnosis and treatment of multiple sclerosis. BMJ, 332, 525–527. doi:332/7540/525 [pii];10.1136/bmj.332.7540.525
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health. (2011). Depression in Adults (update). Retrieved from: https://www.nice.org.uk/guidance/qs8
   Google Scholar
• Pakenham, K.I. (1999). Adjustment to multiple sclerosis: Application of a stress and coping model. Health Psychology, 18, 383–392. doi:10.1037/0278-6133.18.4.383
   PubMed Web of Science ®Google Scholar
• Patel, R., Reiss, P., Shetty, H., Broadbent, M., Stewart, R., McGuire, P., & Taylor, M. (2015). Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study. BMJ Open, 5, e008341. doi:10.1136/bmjopen-2015-008341
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Beck, C.A., Williams, J.V.A., Barbui, C., & Metz, L. (2003). Major depression in multiple sclerosis: A population-based perspective. Neurology, 61, 1524–1527.
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Berzins, S., & Metz, L.M. (2010). Challenges in screening for depression in multiple sclerosis. Multiple Sclerosis, 16, 1406–1411. doi:10.1177/1352458510377770
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Burton, J.M., Fiest, K.M., Wiebe, S., Bulloch, A.G., Koch, M., … Jette, N. (2015). Validity of four screening scales for major depression in MS. Multiple Sclerosis, 21, 1064–1071. doi:10.1177/1352458514559297
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Francis, G., Metz, L.M., Lopez-Bresnahan, M., Chang, P., & Curtin, F. (2005). The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis. Multiple Sclerosis, 11, 175–181. doi:10.1191/1352458505ms1144oa
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Fridhandler, S., Beck, C.A., & Metz, L.M. (2003). Depressive symptoms in a treated multiple sclerosis cohort. Multiple Sclerosis, 9, 616–620. doi:10.1191/1352458503ms960oa
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Lavorato, D.H., & Metz, L.M. (2005). Clinical correlates of CES-D depressive symptom ratings in an MS population. General Hospital Psychiatry, 27, 439–445. doi:10.1016/j.genhosppsych.2005.06.010
   PubMed Web of Science ®Google Scholar
• Patten, S.B., & Metz, L.M. (2001). Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: An analysis of depression data from the PRISMS clinical trial. Multiple Sclerosis, 7, 243–248. doi:10.1177/135245850100700406
   PubMed Web of Science ®Google Scholar
• Patten, S.B., & Metz, L.M. (2002). Interferon beta1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial. Neurology, 59, 744–746. doi:10.1212/WNL.59.5.744
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Metz, L.M., & Reimer, M.A. (2000). Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Multiple Sclerosis, 6, 115–120. doi:10.1191/135245800678827536
   PubMed Web of Science ®Google Scholar
• Patten, S.B., & Schopflocher, D. (2009). Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9). Comprehensive Psychiatry, 50, 26–33. doi:10.1016/j.comppsych.2008.05.012
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Wang, J.L., Williams, J.V., Currie, S., Beck, C.A., Maxwell, C.J., & El-Guebaly, N. (2006). Descriptive epidemiology of major depression in Canada. The Canadian Journal of Psychiatry, 51, 84–90. doi:10.1177/070674370605100204
   PubMed Web of Science ®Google Scholar
• Patten, S.B., Williams, J.V.A., Lavorato, D., Wang, J.L., McDonald, K., & Bulloch, A. (2014). Descriptive epidemiology of major depressive disorder in Canada in 2012. The Canadian Journal of Psychiatry, 60, 23–30. doi:10.1177/070674371506000106
   Web of Science ®Google Scholar
• Quesnel, S., & Feinstein, A. (2004). Multiple sclerosis and alcohol: A study of problem drinking. Multiple Sclerosis, 10, 197–201. doi:10.1191/1352458504ms992oa
   PubMed Web of Science ®Google Scholar
• Sacco, R., Santangelo, G., Stamenova, S., Bisecco, A., Bonavita, S., Lavorgna, L., … Gallo, A. (2016). Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. The European Journal of Neurology, 23, 744–750. doi:10.1111/ene.12932
   PubMed Web of Science ®Google Scholar
• Sadovnick, A. D., Remick, R. A., Allen, J., Swartz, E., Yee, I. M. L., Eisen, K., … Paty, D. W. (1996). Depression and multiple sclerosis. Neurology, 46, 628–632
   PubMed Web of Science ®Google Scholar
• Salehpoor, G., Rezaei, S., & Hosseininezhad, M. (2014). Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran. Iranian Journal of Nursing and Midwifery Research, 19, 593–599.
   PubMedGoogle Scholar
• Schiffer, R.B., & Wineman, N.M. (1990). Antidepressant pharmacotherapy of depression associated with multiple sclerosis. The American Journal of Psychiatry, 147, 1493–1497. doi:10.1176/ajp.147.11.1493
   PubMed Web of Science ®Google Scholar
• Schippling, S., O'Connor, P., Knappertz, V., Pohl, C., Bogumil, T., Suarez, G., … Arnason, B. (2016). Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. Journal of Neurology, 263, 1418–1426. doi:10.1007/s00415-016-8146-8
   PubMed Web of Science ®Google Scholar
• Snaith, R.P., & Zigmond, A.S. (1986). The hospital anxiety and depression scale. British Medical Journal Clinical Research Ed, 292, 344. doi:10.1136/bmj.292.6516.344
   PubMed Web of Science ®Google Scholar
• Solaro, C., Bergamaschi, R., Rezzani, C., Mueller, M., Trabucco, E., Bargiggia, V., … Cavalla, P. (2013). Duloxetine is effective in treating depression in multiple sclerosis patients: An open-label multicenter study. Clinical Neuropharmacology, 36, 114–116. doi:10.1097/WNF.0b013e3182996400
   PubMed Web of Science ®Google Scholar
• Solaro, C., Trabucco, E., Signori, A., Martinelli, V., Radaelli, M., Centonze, D., … Truini, A. (2016). Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian Multi-Center Study using the beck depression inventory. PLoS One, 11, e0160261. doi:10.1371/journal.pone.0160261
   PubMed Web of Science ®Google Scholar
• Spitzer, R.L., Kroenke, K., Williams, J.B.W., & Group, T.P.H.Q.P.C.S. (1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA, 282, 1737–1744. doi:10.1001/jama.282.18.1737
   PubMed Web of Science ®Google Scholar
• Udina, M., Castellvi, P., Moreno-Espana, J., Navines, R., Valdes, M., Forns, X., … Martin-Santos, R. (2012). Interferon-induced depression in chronic hepatitis C: A systematic review and meta-analysis. The Journal of Clinical Psychiatr, 73, 1128–1138. doi:10.4088/JCP.12r07694
   PubMed Web of Science ®Google Scholar
• Udina, M., Hidalgo, D., Navines, R., Forns, X., Sola, R., Farre, M., … Martin-Santos, R. (2014). Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: A systematic review and meta-analysis. The Journal of Clinical Psychiatr, 75, e1113–e1121. doi:10.4088/JCP.13r08800
   PubMed Web of Science ®Google Scholar
• Vilagut, G., Forero, C.G., Barbaglia, G., & Alonso, J. (2016). Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A systematic review with meta-analysis. PLoS One, 11, e0155431 doi:10.1371/journal.pone.0155431
   PubMed Web of Science ®Google Scholar
• Viner, R., Fiest, K.M., Bulloch, A.G., Williams, J.V., Lavorato, D.H., Berzins, S., … Patten, S.B. (2014). Point prevalence and correlates of depression in a national community sample with multiple sclerosis. General Hospital Psychiatry, 36, 352–354. doi:10.1016/j.genhosppsych.2013.12.011
   PubMed Web of Science ®Google Scholar
• Viner, R., Patten, S.B., Berzins, S., Bulloch, A.G., & Fiest, K.M. (2014). Prevalence and risk factors for suicidal ideation in a multiple sclerosis population. Journal of Psychosomatic Research, 76, 312–316. doi:10.1016/j.jpsychores.2013.12.010
   PubMed Web of Science ®Google Scholar
• Watson, T.M., Ford, E., Worthington, E., & Lincoln, N.B. (2014). Validation of mood measures for people with multiple sclerosis. International Journal of MS Care, 16, 105–109. doi:10.7224/1537-2073.2013-013
   PubMedGoogle Scholar
• Weinshenker, B.G., Bass, B., Rice, G.P.A., Noseworthy, J., Carriere, W., Baskerville, J., & Ebers, G.C. (1989). The natural history of multiple sclerosis: A geographically based study. 1. Clinical course and disability. Brain, 112, 133–146. doi:10.1093/brain/112.1.133
   PubMed Web of Science ®Google Scholar
• Yates, W.R., Wesner, R.B., & Thompson, R. (1991). Organic mood disorder: A valid psychiatry consultation diagnosis? Journal of Affective Disorders, 22, 37–42. doi:10.1016/0165-0327(91)90081-3
   PubMed Web of Science ®Google Scholar
• Zabad, R.K., Patten, S.B., & Metz, L.M. (2005). The association of depression with disease course in multiple sclerosis. Neurology, 64, 359–360. doi:10.1212/01.WNL.0000149760.64921.AA
   PubMed Web of Science ®Google Scholar
• Zephir, H., De Seze, J., Stojkovic, T., Delisse, B., Ferriby, D., Cabaret, M., & Vermersch, P. (2003). Multiple sclerosis and depression: Influence of interferon beta therapy. Multiple Sclerosis, 9, 284–288. doi:10.1191/1352458503ms915oa
   PubMed Web of Science ®Google Scholar